BlackRock Fund Advisors - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 185 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$112,230,000
+14.8%
4,444,772
+12.5%
0.02%
+5.0%
Q3 2016$97,742,000
+54.8%
3,952,348
+27.5%
0.02%
+42.9%
Q2 2016$63,132,000
+46.4%
3,099,268
+9.6%
0.01%
+40.0%
Q1 2016$43,112,000
+14.7%
2,826,989
+1.1%
0.01%
+11.1%
Q4 2015$37,575,000
-4.8%
2,795,751
-0.6%
0.01%
-10.0%
Q3 2015$39,475,000
-6.4%
2,813,608
+13.3%
0.01%0.0%
Q2 2015$42,156,000
+157.0%
2,482,690
+83.0%
0.01%
+150.0%
Q1 2015$16,404,000
+48.1%
1,356,816
+1.7%
0.00%
+33.3%
Q4 2014$11,076,000
+5.0%
1,334,515
+9.9%
0.00%0.0%
Q3 2014$10,549,000
-20.1%
1,213,913
+0.7%
0.00%
-25.0%
Q2 2014$13,199,000
+51.3%
1,205,400
+23.6%
0.00%
+33.3%
Q1 2014$8,721,000
+40.4%
975,519
+18.4%
0.00%
+50.0%
Q4 2013$6,210,000
+12.4%
823,633
+9.3%
0.00%0.0%
Q3 2013$5,524,000
+31.2%
753,576
+15.1%
0.00%0.0%
Q2 2013$4,209,000654,6470.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders